STERIS logo

STERIS

STENYSEStock Fundamentals

STERIS plc is a leading global provider of infection prevention and procedural products and services focused on healthcare, medical device, and pharmaceutical markets. The company helps customers create a healthier and safer world through a unique mix of consumables, capital equipment, and outsourced services. Its core value proposition centers on supporting patient care through comprehensive sterilization, disinfection, and surgical solutions.

Market Cap$20.9B
Revenue TTM$5.8B
Net Income TTM$707.8M
P/E Ratio29.49
Net Margin12.15%
EPS TTM$7.16
Free Cash Flow TTM$917.1M
Employees18.2K
CEODaniel A. Carestio
CountryIreland
Healthcare
Medical - Devices
SegmentsMedical Devices, Life Sciences Tools & Services, Healthcare Equipment
Business ModelsManufacturing, Outsourced services, Consumables, Maintenance and repair
Most Recent EarningsMay 11, 2026 · 9 days agoQ1 2026 · FQ4 FY2026
View report
Next EarningsAug 5, 2026 · in 2 monthsAfter Market Close · Q2 2026 · FQ1 FY2027

Financials

Based on Q1 2026 · FQ4 FY2026 filing

Gross Margin44.11%
Op. Margin17.18%
ROE10.43%
D/E27.02%
Current Ratio2.48
Total Debt$1.9B
Cash$423.7M
CapEx TTM$349.7M

Gross Profit

View metric

Net Income

View metric

Operating Cash Flow

View metric

Free Cash Flow

View metric

EPS (Diluted)

View metric

Business Segments

Healthcare

primary

Provides a comprehensive offering for healthcare providers focused on sterile processing departments and procedural centers like operating rooms and endoscopy suites. It combines infection prevention consumables and capital equipment with maintenance and outsourced instrument reprocessing services.

Products

Prolystica Ultra Concentrate Cleaning Chemistries, automated endoscope reprocessing systems, surgical tables, surgical lights, endoscopy accessories, sterilizers, washers

Customers

Hospitals, Ambulatory surgery centers, Endoscopy suites

Applied Sterilization Technologies (AST)

major

Supports medical device and pharmaceutical manufacturers through a global network of contract sterilization and laboratory testing facilities. The segment utilizes a technology-neutral approach to provide process validation and microbial reduction services for single-use sterile products.

Products

contract sterilization services, laboratory testing services, accelerators, product handling automation, process controls, monitoring systems

Customers

Medical device manufacturers, Pharmaceutical manufacturers, Research institutions

Life Sciences

moderate

Focuses on supporting biopharmaceutical and medical device manufacturing facilities, particularly those involved in aseptic manufacturing. The portfolio includes pharmaceutical-grade detergents, cleanroom disinfectants, and specialized capital equipment for decontamination.

Products

pharmaceutical detergents, cleanroom disinfectants, vaporized hydrogen peroxide room decontamination systems, high purity water generators, pure steam generators

Customers

Biopharmaceutical manufacturers, Medical device manufacturers, Research laboratories

Segment Financials

Applied Sterilization Technologies — R&D

View metric

Healthcare — Revenue

View metric

Applied Sterilization Technologies — Revenue

View metric

Applied Sterilization Technologies — Total Assets

View metric

Life Sciences: — Revenue

View metric

Business Overview

Competitive Position

A leading global provider with a significant installed base of capital equipment and a comprehensive network of contract sterilization facilities.

Geographies

Americas, Europe, Asia, Ireland

Customer Segments

Hospitals, Pharmaceutical companies, Medical device OEMs

Upstream Dependencies

Stainless and carbon steel suppliers, Organic and inorganic chemical producers, Ethylene oxide (EO) suppliers, Radioisotope cobalt-60 suppliers, Plastic component manufacturers

Downstream Customers

Acute care hospitals, Pharmaceutical manufacturers, Medical device OEMs, Ambulatory surgery centers

STERIS logo

STERIS FAQ

Common questions about STERIS

STERIS plc is a leading global provider of infection prevention and procedural products and services focused on healthcare, medical device, and pharmaceutical markets. The company helps customers create a healthier and safer world through a unique mix of consumables, capital equipment, and outsourced services. Its core value proposition centers on supporting patient care through comprehensive sterilization, disinfection, and surgical solutions.

STERIS (STE) has a market capitalization of $20.9B and trades on NYSE.

STERIS generated $5.8B in trailing twelve-month revenue with net income of $707.8M, representing a net margin of 12.2%. Gross margin stands at 44.1%, with free cash flow of $917.1M. These figures are based on the Q4 2025 filing.

STERIS's key competitors include Ecolab, Stryker, Boston Scientific, and others. These companies compete in similar markets and product categories.

STERIS has approximately 18,179 employees.